{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:58:05Z","timestamp":1761562685010,"version":"3.37.3"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1-AI068619"],"award-info":[{"award-number":["UM1-AI068619"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5R01DK108424"],"award-info":[{"award-number":["5R01DK108424"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,4]]},"DOI":"10.1093\/infdis\/jiaa555","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T19:16:59Z","timestamp":1598987819000},"page":"1-3","source":"Crossref","is-referenced-by-count":6,"title":["Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations"],"prefix":"10.1093","volume":"223","author":[{"given":"Myron S","family":"Cohen","sequence":"first","affiliation":[{"name":"Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael J","family":"Landovitz","sequence":"additional","affiliation":[{"name":"Center for Clinical AIDS Research and Education, University of California, Los Angeles, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"2021010414101928600_CIT0001","article-title":"Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals","author":"Jenness","year":"2020","journal-title":"medRxiv [Preprint]"},{"year":"2012","key":"2021010414101928600_CIT0002"},{"key":"2021010414101928600_CIT0003"},{"key":"2021010414101928600_CIT0004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/aid.2018.0031","article-title":"Weighing the evidence of efficacy of oral PrEP for HIV prevention in women in southern Africa","volume":"34","author":"Janes","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"year":"2019","key":"2021010414101928600_CIT0005"},{"key":"2021010414101928600_CIT0006","doi-asserted-by":"crossref","first-page":"e788","DOI":"10.1016\/S2352-3018(19)30238-3","article-title":"Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline","volume":"6","author":"Coelho","year":"2019","journal-title":"Lancet HIV"},{"key":"2021010414101928600_CIT0007","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection","volume":"382","author":"Orkin","year":"2020","journal-title":"N Engl J Med"},{"key":"2021010414101928600_CIT0008","doi-asserted-by":"crossref","first-page":"e1002690","DOI":"10.1371\/journal.pmed.1002690","article-title":"Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial","volume":"15","author":"Landovitz","year":"2018","journal-title":"PLoS Med"},{"key":"2021010414101928600_CIT0009","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2352-3018(20)30106-5","article-title":"Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial","volume":"7","author":"Landovitz","year":"2020","journal-title":"Lancet HIV"},{"key":"2021010414101928600_CIT0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/infdis\/jiaa552","article-title":"Projected impact of concurrently available long-acting injectable and daily-oral HIV pre-exposure prophylaxis: a mathematical model","volume":"223","author":"Maloney","year":"2020","journal-title":"J Infect Dis"},{"key":"2021010414101928600_CIT0011","doi-asserted-by":"crossref","first-page":"100386","DOI":"10.1016\/j.epidem.2020.100386","article-title":"Egocentric sexual networks of men who have sex with men in the United States: results from the ARTnet study","volume":"30","author":"Weiss","year":"2020","journal-title":"Epidemics"},{"key":"2021010414101928600_CIT0012","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2352-3018(18)30097-3","article-title":"Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study","volume":"5","author":"Marshall","year":"2018","journal-title":"Lancet HIV"},{"key":"2021010414101928600_CIT0013","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/infdis\/jiv523","article-title":"Potential clinical and economic value of long-acting preexposure prophylaxis for South African women at high-risk for HIV infection","volume":"213","author":"Walensky","year":"2016","journal-title":"J Infect Dis"},{"key":"2021010414101928600_CIT0014","doi-asserted-by":"crossref","first-page":"ofw125","DOI":"10.1093\/ofid\/ofw125","article-title":"Deciphering the effects of injectable pre-exposure prophylaxis for combination human immunodeficiency virus prevention","volume":"3","author":"Glaubius","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2021010414101928600_CIT0015","article-title":"HPTN083 interim results: pre-exposure prophylaxis containing long-acting injectable cabotegravir is safe and highly effective for cisgender men and transgender women who have sex with men","volume-title":"[abstract OAXLB0101]","author":"Landovitz","year":"2020"},{"key":"2021010414101928600_CIT0016","article-title":"Long acting cabotegravir: planning for success across global at-risk populations","volume-title":"[abstract 11884]","author":"Delany-Moretlwe","year":"2020"},{"key":"2021010414101928600_CIT0017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cid\/civ289","article-title":"The high risk of an HIV diagnosis following a diagnosis of syphilis: a population-level analysis of New York City men","volume":"61","author":"Pathela","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021010414101928600_CIT0018","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV Epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"2021010414101928600_CIT0019","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","article-title":"The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa555\/34134693\/jiaa555.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/1\/1\/35388246\/jiaa555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/1\/1\/35388246\/jiaa555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T11:28:01Z","timestamp":1617103681000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/1\/1\/5901096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,3]]},"published-print":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa555","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,9,3]]}}}